-+ 0.00%
-+ 0.00%
-+ 0.00%

Guggenheim Maintains Buy on Immatics, Raises Price Target to $19

Benzinga·11/18/2025 14:18:57
Listen to the news
Guggenheim analyst Paul Jeng maintains Immatics (NASDAQ:IMTX) with a Buy and raises the price target from $16 to $19.